Ontogenetic  Market Research Report- Global Forecast till 2023

Ontogenetic Market Research Report- Global Forecast till 2023

ID: MRFR/HC/0358-HCRR | January, 2018 | Region: Global | 75 pages | Half-Cooked Research Reports

Ontogenetic Market Information: By Devices (Electroencephalography, Magnetoencephalography), Application (Developmental Biology, Developmental Psychology), End User (Research Laboratories, Academic Institutes, Others) - Global Forecast till 2023 


Market Scenario


Ontogenetic is a developmental history of an organism, which includes the study of cognitive, physical, social, and emotional development, which can be attributed to experience with the individuals and the environment within the environment. Ontogenetic is a vast subject and continuous research in the field is expanding its applications. Increasing human and animal population is one of the major factors affecting the market growth, positively. Furthermore, increasing funding for research is one of the major driving factors of the market. Epilepsy is the disorder of a nervous system. According to the last updated report on February 2017 by World Health Organization (WHO), around 50 million people are affected with epilepsy globally, and it affects people of all ages. The report suggests that around 2.4 million people are diagnosed with epilepsy every year globally.


Companies are focusing on merger and also collaborating with universities or academic institutes for further study on ontogenetic. In this regards, in March 2016, Natus Medical Incorporated announced its expansion of neurodiagnostic services into seven new states with the acquisition of the assets of NeuroQuest, LLC. This acquisition helped Natus Medical Incorporated in expanding their network globally and helped to increase the market share. Rapidly changing technology plays an important role in the growth of this market. Technological advancement is opening new doors to the ontogenetic research and use.


Governments of different nations have done various developments to encourage research, which is driving the market growth. Increasing adoption of various oncologic practices owing to rising patient population having a nervous disorder. According to the last updated report on February 2017 by the World Health Organization (WHO), annually 30-50 cases are diagnosed per 100 000 people, whereas, in low and middle-income countries, this figure is up to two times higher.


The developed countries are holding major market share owing to the availability of advanced infrastructure, skilled professionals, and high expenditure, but the market is rapidly expanding in emerging countries such as India, China, and Brazil. The research activities in Pacific region, especially, in Australia is increasing and is expected to grow significantly during the forecast period.


The global Ontogenetic market is expected to grow at a CAGR of 4.2% during the forecast period 2017-2023. 


Intended Audience



  • Ontogenetic Services Providers

  • Hospitals and Clinics

  • Medical Research Laboratories

  • Research and Development Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

  • Government Policy Makers and Authorities 


Figure: Global Ontogenetic Market, By Region Market Share, 2016 (%)

Ontogenetic Market


Sources: Annual reports, Press release, White paper, Company presentation


 


Segmentations


The global ontogenetic market is segmented on the basis of devices, application, and end user.


On the basis of the devices, it is segmented into electroencephalography, magnetoencephalography, and others.


On the basis of the application, it is segmented into developmental biology, developmental psychology, developmental cognitive neuroscience, developmental psychobiology, and others.


On the basis of the end user, it is segmented into research laboratories, academic institutes, and others. Furthermore, the research laboratories are segmented into government research laboratories, independent or private research laboratories, and others.


Regional Analysis


The Americas dominate the global ontogenetic market owing to a large amount of money invested in the research and development and clinical trials. The Americas mainly includes North America and South America. North America is the leading regional market, whereas South America ontogenetic market is also growing at a significant rate. The U.S. is the highest revenue generating country within the region.


The European market is the second largest and is expected to grow exponentially during the forecast period. Major European countries like Germany, France, and the U.K are driving this market. On the other hand, Eastern European countries are also contributing a major share to this regional market growth. The U.K is expected to grow at a healthy CAGR in the European ontogenetic market.


The Asia Pacific is the fastest growing ontogenetic market owing to increasing funding for research and development and government initiatives to encourage such research. China and Japan are the major players in this region, while India is emerging as the fastest growing country in this market.


However, lack of developed infrastructure, low investment in research and development are likely to slow the Middle East & African market growth.  


Key Players


Some of key the players in the market are ANT Neuro (the Netherlands), EMS Handels Gesellschaft mbH (Austria), Natus Medical Incorporated (U.S.), Ontogeny, Inc (U.S.), Symbiotic Devices (Australia), and others.


Research Methodology

Global Ontogenetic Market


Sources: Annual reports, Press release, White paper, and Company presentation





 

 Table of Content    

1.    Report Prologue    

2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment            

5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

6.    Global Ontogenetic Market, by Devices

     6.1    Introduction

      6.2    Electro encephalography

            6.2.1    Market Estimates & Forecast, 2017-2023

      6.3    Magneto encephalography

            6.3.1    Market Estimates & Forecast, 2017-2023

      6.4    Others

            6.4.1    Market Estimates & Forecast, 2017-2023

7.    Global Ontogenetic Market, by Application

     7.1    Introduction

      7.2    Developmental Biology

            7.2.1    Market Estimates & Forecast, 2017-2023

      7.3    Developmental Psychology

            7.3.1    Market Estimates & Forecast, 2017-2023

      7.4    Developmental Cognitive Neuroscience

            7.4.1    Market Estimates & Forecast, 2017-2023

      7.5    Developmental psychobiology

            7.5.1    Market Estimates & Forecast, 2017-2023

    7.6    Others

            7.6.1    Market Estimates & Forecast, 2017-2023

8.    Global Ontogenetic Market, by End User

      8.1    Introduction

      8.2    Research laboratories

            8.2.1    Market Estimates & Forecast, 2017-2023

      8.3    Academic Institutes

            8.3.1    Market Estimates & Forecast, 2017-2023

      8.4    Others

            8.4.1    Market Estimates & Forecast, 2017-2023

9.    Global Ontogenetic Market, by Region

      9.1    Introduction

      9.2    Americas

            9.2.1    North America

                9.2.1.1    U.S.

                9.2.1.2    Canada

            9.2.2    South America

      9.3    Europe

            9.3.1    Western Europe

                9.3.1.1    Germany

                9.3.1.2    France

                9.3.1.3    U.K.

                9.3.1.4    Italy

                9.3.1.5    Spain

                9.3.1.6    Rest of Western Europe

            9.3.2    Eastern Europe

      9.4    Asia Pacific

            9.4.1    Japan

            9.4.2    China

            9.4.3    India

            9.4.4    Australia

            9.4.5    Republic of Korea

            9.4.6    Rest of Asia Pacific

      9.5    The Middle East & Africa

            9.5.1    United Arab Emirates

            9.5.2     Saudi Arabia

            9.5.3    Oman

            9.5.4    Kuwait

            9.5.5    Qatar

            9.5.6    Rest of the Middle East & Africa

10    Company Landscape    

      10.1    Introduction    

      10.2    Market Share Analysis    

      10.3    Key Development & Strategies    

            10.3.1    Key Developments    

11    Company Profiles    

      11.1    ANT Neuro

            11.1.1    Company Overview    

            11.1.2    Product Overview    

            11.1.3    Financials    

            11.1.4    SWOT Analysis    

      11.2    Core Tech Solutions Inc

            11.2.1    Company Overview    

            11.2.2    Product Overview    

            11.2.3    Financial Overview    

            11.2.4    Key Developments    

            11.2.5    SWOT Analysis    

      11.3    EMS Handels Gesellschaft mbH

            11.3.1    Company Overview    

            11.3.2    Product Overview    

            11.3.3    Financial Overview

            11.3.4    Key Development    

            11.3.5    SWOT Analysis    

      11.4    Natus Medical Incorporated

            11.4.1    Company Overview    

            11.4.2    Product/Business Segment Overview    

            11.4.3    Financial Overview    

            11.4.4    Key Development    

            11.4.5    SWOT Analysis    

      11.5    Ontogeny, Inc

            11.5.1    Company Overview    

            11.5.2    Product Overview    

            11.5.3    Financial overview    

            11.5.4    Key Developments    

      11.6    Symbiotic Devices

            11.6.1    Company Overview    

            11.6.2    Product Overview    

            11.6.3    Financial Overview    

            11.6.4    Key Developments    

    11.7    Others

12    MRFR Conclusion    

      12.1    Key Findings    

            12.1.1    From CEO’s View Point    

            12.1.2    Unmet Needs of the Market    

      12.2    Key Companies to Watch    

      12.3    Prediction of Pharmaceutical Industry

13    Appendix   





LIST OF TABLES

Table 1        Ontogenetic Industry Synopsis, 2017-2023

Table 2        Global Ontogenetic Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3        Global Ontogenetic Market by Region, 2017-2023, (USD Million)

Table 4        Global Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 5        Global Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 6        Global Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 7        North America Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 8     North America Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 9     North America Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 10    US Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 11    US Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 12    US Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 13    Canada Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 14    Canada Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 15    Canada Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 16    South America Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 17    South America Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 18    South America Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 19    Europe Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 20    Europe Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 21    Europe Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 22    Western Europe Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 23    Western Europe Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 24    Western Europe Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 25    Eastern Europe Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 26    Eastern Europe Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 27    Eastern Europe Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 28    Asia Pacific Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 29    Asia Pacific Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 30    Asia Pacific Ontogenetic Market by End Users, 2017-2023, (USD Million)

Table 31    Middle East & Africa Ontogenetic Market by Devices, 2017-2023, (USD Million)

Table 32    Middle East & Africa Ontogenetic Market by Application, 2017-2023, (USD Million)

Table 33    Middle East & Africa Ontogenetic Market by End Users, 2017-2023, (USD Million)



LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Global Ontogenetic Market

Figure 3    Segmentation Market Dynamics for Ontogenetic Market

Figure 4    Global Ontogenetic Market Share, by Devices 2016

Figure 5    Global Ontogenetic Market Share, by Application 2016

Figure 6    Global Ontogenetic Market Share, by End Users, 2016

Figure 7    Global Ontogenetic Market Share, by Region, 2016

Figure 8    America Ontogenetic Market Share, by Country, 2016

Figure 9    Europe Ontogenetic Market Share, by Country, 2016

Figure 10    Asia Pacific Ontogenetic Market Share, by Country, 2016

Figure 11    Middle East & Africa Ontogenetic Market Share, by Country, 2016

Figure 12    Global Ontogenetic Market: Company Share Analysis, 2016 (%)

Figure 13    ANT Neuro: Key Financials

Figure 14    ANT Neuro: Segmental Revenue

Figure 15    ANT Neuro: Geographical Revenue

Figure 16    Core Tech Solutions Inc: Key Financials

Figure 17    Core Tech Solutions Inc: Segmental Revenue

Figure 18    Core Tech Solutions Inc: Geographical Revenue

Figure 19    EMS Handels Gesellschaft mbH: Key Financials

Figure 20    EMS Handels Gesellschaft mbH: Segmental Revenue

Figure 21    EMS Handels Gesellschaft mbH: Geographical Revenue

Figure 22    Natus Medical Incorporated: Key Financials

Figure 23    Natus Medical Incorporated: Segmental Revenue

Figure 24    Natus Medical Incorporated: Geographical Revenue

Figure 25    Ontogeny, Inc: Key Financials

Figure 26    Ontogeny, Inc: Segmental Revenue

Figure 27    Ontogeny, Inc: Geographical Revenue

Figure 28    Symbiotic Devices: Key Financials

Figure 29    Symbiotic Devices: Segmental Revenue

Figure 30    Symbiotic Devices: Geographical Revenue